Preventing heart damage from cancer treatment
Part of Cancer, Heart & circulation clinical trials.
This trial tracks how cancer treatments affect the heart. It may help doctors find ways to prevent heart problems during your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with cancer and your doctor plans to start treatment.
- You expect to live longer than one year from now.
- If you have newly diagnosed breast cancer and are getting a specific type of chemotherapy (anthracyclines), that is especially useful for this study.
- You must be able to understand and agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how anthracycline chemotherapy affects the heart and blood vessels in children and teens who had cancer. It aims to help doctors better understand long-term heart risks and follow-up care.
This trial uses a special scoring system (ML Score) to predict if you might develop heart problems while receiving anthracycline chemotherapy or HER2-targeted therapies. It helps doctors decide on the best heart monitoring plan before starting treatment.
This study tracks how well the heart handles HER2-targeted therapy (like Herceptin) during the first year of treatment for early-stage breast cancer. It helps keep you safe by checking heart function closely.
This study helps doctors predict which cancer patients are at higher risk of heart problems from their cancer treatments. By tracking your heart health before, during, and after treatment, researchers can develop better ways to protect your heart.
This feasibility study looks at how to support decision-making about preventing heart problems in adults after a cancer diagnosis. It may help by making it easier to assess cardiovascular risk and start appropriate heart-protection planning earlier.
This study uses heart imaging scans and blood tests to check if a common cancer drug (anthracycline) is affecting your heart during treatment. Early detection might help doctors protect your heart health.
Hear when a new Cancer Related Cardiovascular Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.